(EMR) Emerson Electric - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2910111044
EMR: Valves, Actuators, Regulators, Instruments, Software, Systems
Emerson Electric Co. (NYSE: EMR) is a global leader in technology and software, delivering cutting-edge solutions across the Americas, Asia, the Middle East, Africa, and Europe. The company operates through seven distinct segments, each targeting specific industrial needs. Its Final Control segment specializes in critical flow control technologies, ensuring safety and efficiency in process industries. Measurement & Analytical provides advanced tools for monitoring physical properties, crucial for optimizing industrial processes.
The Discrete Automation segment offers components essential for manufacturing, enabling precise control and automation in production lines. Safety & Productivity focuses on professional tools, enhancing workplace efficiency and safety. Control Systems & Software delivers digital solutions, including cybersecurity and asset management, vital for modern industrial operations. Test & Measurement ensures precision and quality through advanced testing systems, while AspenTech provides software for operational optimization, enhancing performance and efficiency.
With a market cap of $70.66B, Emersons financials reflect its industry standing, with a P/E ratio of 35.30 and forward P/E of 21.05. This underscores its potential for growth and value creation, making it a notable player in the Electrical Components & Equipment sector.
Additional Sources for EMR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
EMR Stock Overview
| Market Cap in USD | 70,657m |
| Sector | Industrials |
| Industry | Specialty Industrial Machinery |
| GiC Sub-Industry | Electrical Components & Equipment |
| IPO / Inception | 1972-06-01 |
EMR Stock Ratings
| Growth 5y | 65.6% |
| Fundamental | -3.76% |
| Dividend | 56.1% |
| Rel. Strength Industry | 2.03 |
| Analysts | 4.25/5 |
| Fair Price Momentum | 110.24 USD |
| Fair Price DCF | 36.41 USD |
EMR Dividends
| Dividend Yield 12m | 1.79% |
| Yield on Cost 5y | 3.41% |
| Annual Growth 5y | 0.95% |
| Payout Consistency | 100.0% |
EMR Growth Ratios
| Growth Correlation 3m | -44.6% |
| Growth Correlation 12m | 54% |
| Growth Correlation 5y | 79.9% |
| CAGR 5y | 14.55% |
| CAGR/Max DD 5y | 0.32 |
| Sharpe Ratio 12m | 0.62 |
| Alpha | -8.06 |
| Beta | 1.40 |
| Volatility | 23.42% |
| Current Volume | 2334.4k |
| Average Volume 20d | 2860.1k |
As of February 23, 2025, the stock is trading at USD 121.85 with a total of 2,334,381 shares traded.
Over the past week, the price has changed by -1.21%, over one month by -5.49%, over three months by -4.60% and over the past year by +18.19%.
Neither. Based on ValueRay Fundamental Analyses, Emerson Electric is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -3.76 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EMR as of February 2025 is 110.24. This means that EMR is currently overvalued and has a potential downside of -9.53%.
Emerson Electric has received a consensus analysts rating of 4.25. Therefor, it is recommend to buy EMR.
- Strong Buy: 18
- Buy: 2
- Hold: 6
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, EMR Emerson Electric will be worth about 132.3 in February 2026. The stock is currently trading at 121.85. This means that the stock has a potential upside of +8.57%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 141.9 | 16.5% |
| Analysts Target Price | 140 | 14.9% |
| ValueRay Target Price | 132.3 | 8.6% |